388 related articles for article (PubMed ID: 8536356)
1. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).
Duchmann R; Kaiser I; Hermann E; Mayet W; Ewe K; Meyer zum Büschenfelde KH
Clin Exp Immunol; 1995 Dec; 102(3):448-55. PubMed ID: 8536356
[TBL] [Abstract][Full Text] [Related]
2. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
3. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
[TBL] [Abstract][Full Text] [Related]
4. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease.
Duchmann R; Märker-Hermann E; Meyer zum Büschenfelde KH
Scand J Immunol; 1996 Jul; 44(1):71-9. PubMed ID: 8693294
[TBL] [Abstract][Full Text] [Related]
5. Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD).
MacDonald TT
Clin Exp Immunol; 1995 Dec; 102(3):445-7. PubMed ID: 8536355
[No Abstract] [Full Text] [Related]
6. IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons.
Pullman WE; Doe WF
Clin Exp Immunol; 1992 Apr; 88(1):132-7. PubMed ID: 1563100
[TBL] [Abstract][Full Text] [Related]
7. Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits T cell cytokine production and T-box transcription factor T-bet in inflammatory bowel disease.
Di Sabatino A; Rovedatti L; Kaur R; Spencer JP; Brown JT; Morisset VD; Biancheri P; Leakey NA; Wilde JI; Scott L; Corazza GR; Lee K; Sengupta N; Knowles CH; Gunthorpe MJ; McLean PG; MacDonald TT; Kruidenier L
J Immunol; 2009 Sep; 183(5):3454-62. PubMed ID: 19648266
[TBL] [Abstract][Full Text] [Related]
8. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.
Duchmann R; May E; Heike M; Knolle P; Neurath M; Meyer zum Büschenfelde KH
Gut; 1999 Jun; 44(6):812-8. PubMed ID: 10323882
[TBL] [Abstract][Full Text] [Related]
9. Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.
Ebert EC; Mehta V; Das KM
Clin Exp Immunol; 2005 Apr; 140(1):157-65. PubMed ID: 15762887
[TBL] [Abstract][Full Text] [Related]
10. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.
Rugtveit J; Haraldsen G; Høgåsen AK; Bakka A; Brandtzaeg P; Scott H
Gut; 1995 Sep; 37(3):367-73. PubMed ID: 7590432
[TBL] [Abstract][Full Text] [Related]
11. Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells.
Haller D; Holt L; Parlesak A; Zanga J; Bäuerlein A; Sartor RB; Jobin C
Immunology; 2004 Jun; 112(2):310-20. PubMed ID: 15147574
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of peripheral blood and intestinal mucosa cells by synthetic CpG oligodeoxynucleotides.
Jugdé F; Boissier C; Birebent B; Vu N; D'halluin PN; Rioux-Leclercq N; Bretagne JF; Semana G; Heresebach D
Hum Immunol; 2004 Mar; 65(3):218-30. PubMed ID: 15041160
[TBL] [Abstract][Full Text] [Related]
13. The pathogenic role of intestinal flora in IBD and colon cancer.
Rescigno M
Curr Drug Targets; 2008 May; 9(5):395-403. PubMed ID: 18473768
[TBL] [Abstract][Full Text] [Related]
14. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
[TBL] [Abstract][Full Text] [Related]
15. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
Tom MR; Li J; Ueno A; Fort Gasia M; Chan R; Hung DY; Chenoo S; Iacucci M; Jijon HB; Kaplan GG; Beck PL; Panaccione R; Barkema HW; Buret AG; Yajnik V; Ghosh S
Inflamm Bowel Dis; 2016 Jul; 22(7):1596-608. PubMed ID: 27306067
[TBL] [Abstract][Full Text] [Related]
16. Structural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel disease.
Górska S; Sandstrőm C; Wojas-Turek J; Rossowska J; Pajtasz-Piasecka E; Brzozowska E; Gamian A
Sci Rep; 2016 Nov; 6():37613. PubMed ID: 27869188
[TBL] [Abstract][Full Text] [Related]
17. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
18. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
[TBL] [Abstract][Full Text] [Related]
19. Gut biofilm forming bacteria in inflammatory bowel disease.
Srivastava A; Gupta J; Kumar S; Kumar A
Microb Pathog; 2017 Nov; 112():5-14. PubMed ID: 28942174
[TBL] [Abstract][Full Text] [Related]
20. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
Lord JD; Shows DM; Chen J; Thirlby RC
PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
